Quantbot Technologies’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-6,567
| Closed | -$264K | – | 1916 |
|
|
2026
Q1 | $264K | Buy |
6,567
+959
| +17% | +$20.7K | 0.01% | 1093 |
|
|
2025
Q4 | $141K | Buy |
5,608
+2,795
| +99% | +$65.6K | ﹤0.01% | 1335 |
|
|
2025
Q3 | $63.7K | Buy |
+2,813
| New | +$65.6K | ﹤0.01% | 1493 |
|
|
2024
Q2 | – | Sell |
-1,480
| Closed | -$87K | – | 1413 |
|
|
2024
Q1 | $87K | Buy |
1,480
+883
| +148% | +$56.3K | ﹤0.01% | 1220 |
|
|
2023
Q4 | $35.7K | Sell |
597
-4,201
| -88% | -$213K | ﹤0.01% | 1377 |
|
|
2023
Q3 | $183K | Buy |
4,798
+3,537
| +280% | +$155K | 0.01% | 930 |
|
|
2023
Q2 | $115K | Buy |
+1,261
| New | +$109K | 0.01% | 1144 |
|
|
2021
Q4 | – | Sell |
-2,100
| Closed | -$69K | – | 1474 |
|
|
2021
Q3 | $69K | Sell |
2,100
-4,195
| -67% | -$236K | 0.01% | 1051 |
|
|
2021
Q2 | $397K | Buy |
+6,295
| New | +$325K | 0.03% | 614 |
|
|
2020
Q4 | – | Sell |
-500
| Closed | -$15K | – | 1264 |
|
|
2020
Q3 | $15K | Buy |
+500
| New | +$14.9K | ﹤0.01% | 1043 |
|
|
2019
Q4 | – | Sell |
-1,700
| Closed | -$40K | – | 1200 |
|
|
2019
Q3 | $40K | Buy |
+1,700
| New | +$46.8K | ﹤0.01% | 1021 |
|
|
2018
Q4 | – | Sell |
-6,269
| Closed | -$111K | – | 1017 |
|
|
2018
Q3 | $111K | Buy |
6,269
+638
| +11% | +$11.8K | 0.01% | 858 |
|
|
2018
Q2 | $123K | Buy |
+5,631
| New | +$129K | 0.01% | 832 |
|
Other funds holding APLS
Quantbot Technologies's APLS Position: Q2 2026 in Review
Quantbot Technologies sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 6,567 shares — an estimated $264K sold.
Quantbot Technologies first reported a position in APLS in Q2 2018 and held it in 13 quarters. The position peaked at $397K in Q2 2021. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Quantbot Technologies reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Quantbot Technologies sold 6,567 Apellis Pharmaceuticals shares in Q2 2026, an estimated $264K.
- Quantbot Technologies first reported a position in Apellis Pharmaceuticals in Q2 2018 and held it in 13 quarters.
- Quantbot Technologies's Apellis Pharmaceuticals position peaked at $397K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.